BridgeBio Pharma (BBIO) PT Raised to $64 at Mizuho
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $76.60 -2.64%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Mizuho analyst Salim Syed raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $64.00 (from $60.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $325 at Oppenheimer
- BridgeBio doses first patient in Phase 3b/4 acoramidis heart study
- Elastic NV. (ESTC) PT Raised to $107 at Stifel as Sales Revenue Accelerates
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
